• Celgene buys part of Boston cancer drug firm

    After paying $100 million in 2013 for the option to buy Boston-based Acetylon Pharmaceuticals and then passing on a deal this August, Celgene purchased part of the cancer drug developer on Friday for an undisclosed sum.Privately-held Acetylon, which has 40 employees, said that it had been acquired by Celgene (Nasdaq: CELG). But first, the company will spin out a new firm to develop some of its novel drug candidates. The new entity, Regenacy Pharmaceuticals, will be operated out of Acetylon&rsquo
  • ​Five strategies to grow your middle-market company

    When trying to grow your middle-market company it’s easy to get sidetracked and lose focus on what’s important, here are five strategies to help focus your efforts.Create a 360-degree view of your customer— Customer relationship and customer success tools help to deliver a positive customer experience by allowing businesses to understand universal needs while cultivating a personalized experience. Efforts to fully understand your customer base and to offer seamless support from

Follow @MassNewslocker on Twitter!